The effect of hospital-acquired infection with Clostridium difficile on length of stay in hospital.
about
Isolation of C. difficile Carriers Alone and as Part of a Bundle Approach for the Prevention of Clostridium difficile Infection (CDI): A Mathematical Model Based on Clinical Study Data.The impact of hospital-onset Clostridium difficile infection on outcomes of hospitalized patients with sepsis.Cost and Impact on Patient Length of Stay of Rapid Molecular Testing for Clostridium difficileClinical effects of blood donor characteristics in transfusion recipients: protocol of a framework to study the blood donor-recipient continuumMicrobiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection.Disproportionate rise in Clostridium difficile-associated hospitalizations among US youth with inflammatory bowel disease, 1997-2011.First report of Clostridium difficile NAP1/027 in a Mexican hospitalIs Clostridium difficile infection still a problem for hospitals?Transfusion Patterns in All Patients Admitted to the Intensive Care Unit and in Those Who Die in Hospital: A Descriptive Analysis.Incidence and Costs of Clostridium difficile Infections in CanadaExcess length of stay and economic consequences of adverse events in Dutch hospital patientsEvaluating the Effectiveness of an Antimicrobial Stewardship Program on Reducing the Incidence Rate of Healthcare-Associated Clostridium difficile Infection: A Non-Randomized, Stepped Wedge, Single-Site, Observational Study.National age group trends in Clostridium difficile infection incidence and health outcomes in United States Community Hospitals.Prolongation of length of stay and Clostridium difficile infection: a review of the methods used to examine length of stay due to healthcare associated infectionsThe impact of the introduction of fidaxomicin on the management of Clostridium difficile infection in seven NHS secondary care hospitals in England: a series of local service evaluationsLocal injection of dsRNA targeting calcitonin receptor-like receptor (CLR) ameliorates Clostridium difficile toxin A-induced ileitisThe potential economic value of screening hospital admissions for Clostridium difficile.Clostridium difficile colitis in patients undergoing lower-extremity arthroplasty: rare infection with major impact.Antibodies for treatment of Clostridium difficile infection.The economic impact of Clostridium difficile infection: a systematic review.Cost-effectiveness of outpatient parenteral antibiotic therapy: a simulation modelling approach.Subarachnoid hemorrhage admissions retrospectively identified using a prediction modelComparison of the safety, tolerability, and pharmacokinetics of fidaxomicin in healthy Japanese and caucasian subjectsA mixture of functionally oligoclonal humanized monoclonal antibodies that neutralize Clostridium difficile TcdA and TcdB with high levels of in vitro potency shows in vivo protection in a hamster infection model.Impact of vanB vancomycin-resistant enterococcal bacteraemia analysed as a time-varying covariate on length of hospital stay.Disparity in race-specific comorbidities associated with central venous catheter-related bloodstream infection (AHRQ-PSI7).Attributable burden of hospital-onset Clostridium difficile infection: a propensity score matching study.Identifying predictive features of Clostridium difficile infection recurrence before, during, and after primary antibiotic treatment.Healthcare associated infection and its risk factors among patients admitted to a tertiary hospital in Ethiopia: longitudinal study.
P2860
Q31105341-AD69B94E-5D2D-4328-8A92-64CE632EF302Q33838644-1996015E-A42E-49AF-9B17-E7F505FCABD4Q34726112-EE2D3300-0824-4CA9-A049-2971623CCB33Q35008190-AF26523D-EF8F-4269-9452-15DE45C8D666Q35058570-75D5FB0A-2DCD-41ED-9A0F-F37D54A23500Q35235931-05814E62-1457-4E2F-B67D-6016FC461B22Q35542708-944D8284-3D5C-4561-8D02-2FE336F36AF6Q35664219-774E8BDD-7EC8-46F4-8730-13AF68458828Q35778313-A6BECAFB-C998-4089-817D-7B9C403A3D6AQ35856280-37974B71-FE3E-4A2E-A567-25375EDA0016Q35857749-780C646F-79E7-4FB5-B0C0-6F661C3A5481Q36053985-603C2AE3-B4C8-4B4D-B1D3-BB5F6730292CQ36195428-545089C8-8806-40A7-A50E-CAF26096C02AQ36217689-198EB062-286A-420B-8174-1EBF7BA0433AQ36494422-200C1A77-55DC-40D9-B181-E7890FBC7E88Q36535146-E9985637-E570-4CAD-B12F-CD402FAF5395Q36582287-EF5D74D7-7676-487B-9597-28E4C53B981AQ37170867-BC114E58-999F-4A57-B072-DA8F9A943158Q38208794-D0687746-CBDA-4E5B-BC6F-5E8B808EC157Q38409139-E6202138-499D-4333-B762-7337AD594F72Q38785786-192A5606-DCF0-4FF1-8FF5-63561220420EQ39389684-9BB37D1A-0EF5-4683-8CD5-67DA865F2B98Q41233521-B36C72F9-571D-42AA-B9CE-2EA276B9212FQ41434690-0AE4FE64-1481-4983-8D43-62DE455D28CCQ41675994-6A8B381F-211F-4011-8A31-0DADCD8C85F1Q43487803-F1942D31-2427-4FF2-8C2D-FEF5136FD181Q45958105-F38174DA-84C6-4C45-96CB-3EDC8A0FC012Q46262570-1A9D9E7B-A924-4630-8D5E-02876C03BA6CQ47178113-E1E82579-3C35-45FF-AE75-B73F552AA570
P2860
The effect of hospital-acquired infection with Clostridium difficile on length of stay in hospital.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The effect of hospital-acquire ...... on length of stay in hospital.
@ast
The effect of hospital-acquire ...... on length of stay in hospital.
@en
type
label
The effect of hospital-acquire ...... on length of stay in hospital.
@ast
The effect of hospital-acquire ...... on length of stay in hospital.
@en
prefLabel
The effect of hospital-acquire ...... on length of stay in hospital.
@ast
The effect of hospital-acquire ...... on length of stay in hospital.
@en
P2093
P2860
P356
P1476
The effect of hospital-acquire ...... on length of stay in hospital.
@en
P2093
Alan J Forster
Monica Taljaard
Natalie Oake
Virginia Roth
P2860
P356
10.1503/CMAJ.110543
P407
P577
2011-12-05T00:00:00Z